(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Energy and Utilities
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > In Vitro Diagnostics
 
 
Alternative Scenarios - 3
Blood Banking - 105
Cancer - 92
Clinical Chemistry - 262
Coagulation - 89
Decentralized Testing - 3
DNA Probes/Biochips - 33
Genetic Testing - 1
Hematology/Flow Cytometry - 98
Hemostasis - 70
Histology/Cytology - 2
Immunodiagnostics - 26
Infectious Diseases - 295
Microbiology Testing - 80
Molecular Diagnostics - 141
NAT - 82
POC Testing - 163
Strategic Planning - 24
Top 10 Companies - 22
Transfusion Testing - 84
Tumor Markers - 75
 
 In Vitro Diagnostics Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  95  96  97  98  99  100  101  102  103  104  Next »
Protein Electrophoresis: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA

This new report from VPGMarketResearch.com provides analysis of Protein Electrophoresis testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
AFP: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA

This new report from VPGMarketResearch.com provides analysis of AFP testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
CA 15-3/27-29: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA

This new report from VPGMarketResearch.com provides analysis of CA 15-3/27-29 testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
CA 19-9: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA

This new report from VPGMarketResearch.com provides analysis of CA 19-9 testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
CEA: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA

This new report from VPGMarketResearch.com provides analysis of CEA testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Ferritin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA

This new report from VPGMarketResearch.com provides analysis of Ferritin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Follate (Folic Acid): 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from VPGMarketResearch.com provides analysis of Follate (Folic Acid) testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Glycosylated Hemoglobin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from VPGMarketResearch.com provides analysis of Glycosylated Hemoglobin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
25-Hydroxy Vitamin D2 and D3: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from VPGMarketResearch.com provides analysis of 25-Hydroxy Vitamin D2 and D3 testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Occult Blood: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA

This new report from VPGMarketResearch.com provides analysis of Occult Blood testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
PAP: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from VPGMarketResearch.com provides analysis of PAP testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
PSA: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from VPGMarketResearch.com provides analysis of PSA testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Thyroglobulin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA

This new report from VPGMarketResearch.com provides analysis of Thyroglobulin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Vitamin B-12: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from VPGMarketResearch.com provides analysis of Vitamin B-12 testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Amphetamines: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA

This new report from VPGMarketResearch.com provides analysis of Amphetamines testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Barbiturates: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA

This new report from VPGMarketResearch.com provides analysis of Barbiturates testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Benzodiazepines: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA

This new report from VPGMarketResearch.com provides analysis of Benzodiazepines testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Cannabinoids/Marijuana: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA

This new report from VPGMarketResearch.com provides analysis of Cannabinoids/Marijuana testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
« Previous     95  96  97  98  99  100  101  102  103  104   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X